Read More Pharma Industry News Bristol Myers Squibb CAR T cell therapy Breyanzi shows promising outcomes in clinical trials Bristol Myers Squibb (NYSE: BMY) has unveiled primary analysis results from the TRANSCEND FL clinical trial at the… byPallavi MadhirajuDecember 11, 2023